Obiamiwe C Umeh

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma
    Obiamiwe Chukwudiebere Umeh
    Division of Infectious Diseases, Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA
    Diagn Microbiol Infect Dis 50:71-2. 2004
  2. ncbi request reprint Sex differences in pharmacokinetics and toxicity of antiretroviral therapy
    Obiamiwe C Umeh
    David Geffen School of Medicine at UCLA, Center for Clinical AIDS Research and Education, 9911 W Pico Blvd, Suite 980, Los Angeles, CA 90035, USA
    Expert Opin Drug Metab Toxicol 2:273-83. 2006
  3. ncbi request reprint Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women
    Risa M Hoffman
    Division of Infectious Diseases and Center for Clinical AIDS Research Education, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA
    HIV Clin Trials 8:371-80. 2007
  4. ncbi request reprint Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients
    Obiamiwe C Umeh
    Center for AIDS Research and Education, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Curr HIV/AIDS Rep 2:132-9. 2005

Detail Information

Publications4

  1. ncbi request reprint Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma
    Obiamiwe Chukwudiebere Umeh
    Division of Infectious Diseases, Department of Medicine, UCLA Medical Center, Los Angeles, CA, USA
    Diagn Microbiol Infect Dis 50:71-2. 2004
    ..The epidemiology and clinical features of C. jeikeium infection are discussed. The patient was successfully treated with intravenous vancomycin without recurrence...
  2. ncbi request reprint Sex differences in pharmacokinetics and toxicity of antiretroviral therapy
    Obiamiwe C Umeh
    David Geffen School of Medicine at UCLA, Center for Clinical AIDS Research and Education, 9911 W Pico Blvd, Suite 980, Los Angeles, CA 90035, USA
    Expert Opin Drug Metab Toxicol 2:273-83. 2006
    ..These include, but are not limited to, differences in natural history, efficacy and safety of drug treatment. This chapter reviews current data on gender differences in antiretroviral pharmacokinetics and toxicity...
  3. ncbi request reprint Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women
    Risa M Hoffman
    Division of Infectious Diseases and Center for Clinical AIDS Research Education, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA
    HIV Clin Trials 8:371-80. 2007
    ..This article analyzes three pivotal trials of the protease inhibitor (PI) fosamprenavir (FPV) with a view to providing a better understanding of potential sex differences in efficacy and safety...
  4. ncbi request reprint Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients
    Obiamiwe C Umeh
    Center for AIDS Research and Education, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Curr HIV/AIDS Rep 2:132-9. 2005
    ..This article reviews the current literature on HIV-associated dyslipidemias and the metabolic syndrome, their potential effect on future coronary heart disease, and reviews strategies for management...